Top news of the week: 10.11.2020.
Biotechnology, School, Creative director, Medicinal chemistry, Health care, Systemic lupus erythematosus
Startups
To celebrate outstanding support for #biotechnology education in MA, @MassBioEd is holding its 5th Annual Champions for Biotechnology Education Awards Reception on 11/18. Read our blog to see this year's honorees: https://t.co/eNZTaxZrvR
OpenMassBioEd Champions for Biotechnology Education
To celebrate outstanding support for biotechnology education in Massachusetts, MassBioEd is holding its 5th Annual Champions for Biotechnology Education Awards Reception on Wednesday, ...
RemeGen grabs one of the world's largest ever biotech IPOs https://t.co/vVkNkMTcet https://t.co/KbisaveApL
OpenRemeGen grabs one of the world's largest ever biotech IPOs
RemeGen has raised $515 million on the Hong Kong exchange in one of the largest biotech IPOs ever produced.
Erbi Biosystems Raises $3.8M to Expand Technology Platform.
Funds will be directed toward #microfluidic bioprocess and bioreactor equipment to enable ultra-high cell density and continuous processing. Learn more: https://t.co/RuvCStCzX1 #bioprocessing https://t.co/UemuJufC9M
OpenErbi Biosystems Raises $3.8M to Expand Technology Platform
Funds will be directed toward microfluidic bioprocess and bioreactor equipment to enable ultra-high cell density and continuous processing.
The promise of synthetic biology offers us the chance to redesign life, policy, funding models, business, and equitable access that goes along with it. But biology is advancing fast, and our societal structures must keep pace with the rate of change. https://t.co/d0xYvLTqnm
OpenThe Xenobot Future Is Coming—Start Planning Now
We're on the cusp of being able to program biological systems like we program computers. That raises some thorny questions.
Merck Buys VelosBio, Biogen’s Alzheimer’s Surprise & a Reflection from Wisconsin
My first real journalism job flashed to mind this week. It was 1998-1999. I was a kid reporter fresh out of the University of Wisconsin. My job was to cover Dane County government for The ...
Chutes & Ladders—Novartis alums Jimenez, Fishman unveil their next act https://t.co/oUWoKegqsu https://t.co/Uwdf8N5FO9
OpenChutes & Ladders—Novartis alums Jimenez, Fishman unveil their next act
Novartis alums Jimenez, Fishman unveil their next act, Deep Genomics nabs a CBO from Synlogics, and Santhera's CMO hits the exit.
Just read great article on covalent drugs in @cenmag by @beth_halford ...Great to see Jus Singh with the lead quote - he had such a vision to make this happen. and h/t to @jennifercpetter @NMahanthappa and the whole former Avila team.
https://t.co/Uy7nlaPGbU
OpenCovalent drugs go from fringe field to fashionable endeavor
Designing molecules that make bonds with their biological targets is in vogue
RT @big4bioSD: "Our SARS-CoV-2 & Flu A/Flu B Combination Test leverages reverse transcription-polymerase chain reaction technology to provide 'true PCR' results in about 30 minutes using a handheld device."
#COVID19
https://t.co/pTAYhwrl7W
OpenMesa Biotech to Receive Additional $13 Million from US Health and Human Services to Develop 30 Minute SARS-CoV-2 & Flu A/Flu B Test
/PRNewswire/ -- Mesa Biotech, developers of an affordable, easy to use, handheld testing platform for infectious disease diagnosis, today announced it has been...